ADHD medication in Dubai can help adults with attention-deficit hyperactivity disorder improve concentration, attention, impulse control and everyday functioning. Both stimulant and non-stimulant medications are used, with treatment selected according to individual symptoms, medical history and clinical needs.
Stimulants such as methylphenidate (Ritalin®, Concerta®) and lisdexamfetamine (Vyvanse®) are commonly recommended as first-line pharmacological treatments for adults with ADHD. Atomoxetine (Strattera®) offers a non-stimulant alternative, particularly when stimulant medication is ineffective, unsuitable or poorly tolerated.
The effectiveness of ADHD medication depends on selecting an appropriate preparation, adjusting the dose and monitoring the patient’s response. At CHMC German Clinic for Psychiatry and Psychology in Dubai, Dr. Gregor Kowal provides individualised ADHD medication treatment with regular psychiatric follow-up.
This article explains how ADHD medications work, the differences between available treatments, how long their effects last, possible side effects and the regulations governing ADHD prescriptions in Dubai.
For more information contact our consultant psychiatrist Dr. Kowal
Who Can Benefit from ADHD Medication?
Medication may be appropriate when ADHD symptoms significantly interfere with work, studies, relationships or everyday responsibilities. Difficulties with sustained attention, organisation, impulsivity and completing tasks can persist despite behavioural adjustments and coping strategies.
An ADHD diagnosis does not automatically mean that medication is necessary. The decision depends on the severity of symptoms, their impact on daily functioning, the patient’s medical history and individual treatment preferences. For adults experiencing persistent functional impairment, medication can provide substantial improvement in attention and behavioural regulation. However, treatment response varies, and not every patient benefits equally from the same medicine.
Before starting pharmacological treatment, a psychiatrist should establish whether the symptoms are attributable to ADHD and consider conditions that could influence medication selection.
For further information about the assessment process, read our article on ADHD diagnosis in Dubai.
Types of ADHD Medication Available in Dubai
ADHD medications are divided into two main categories: stimulants and non-stimulants. Both can reduce the core symptoms of ADHD, including inattention, hyperactivity and impulsivity, but they differ in their onset of action, duration of effect and potential side effects.
The choice of medication depends on the patient’s individual symptoms, medical history, previous treatment response and tolerability.
Stimulant ADHD Medication
Stimulants are generally recommended as first-line medication for adults with ADHD. The most commonly prescribed substances include:
- Methylphenidate: Available in immediate-release formulations such as Ritalin® and extended-release preparations such as Concerta®.
- Lisdexamfetamine: Marketed as Vyvanse®, a long-acting stimulant usually taken once daily.
Stimulant medications generally begin working on the day they are taken. Depending on the preparation, their effects may last from approximately three to thirteen hours.
Non-Stimulant ADHD Medication
Non-stimulant medications provide an alternative when stimulants are unsuitable, insufficiently effective or poorly tolerated.
Atomoxetine (Strattera®) is an established non-stimulant treatment for ADHD in adults. Unlike stimulants, its therapeutic effects develop gradually over several weeks rather than immediately after administration.
Other medications, including bupropion and guanfacine, may be considered in selected circumstances, depending on clinical indications, regulatory approval and local availability.
How ADHD Medication Works
ADHD is associated with differences in the functioning of brain networks responsible for attention, executive control and behavioural regulation. Dopamine and noradrenaline are particularly important neurotransmitters within these networks, including the prefrontal cortex.
Stimulant medications increase dopamine and noradrenaline signalling through mechanisms that vary between substances. Methylphenidate primarily inhibits the reuptake of these neurotransmitters, while amphetamine-based medications, including the active metabolite of lisdexamfetamine, also influence their release. This modulation of neurotransmission can improve sustained attention, reduce impulsivity and help patients regulate their activity and behaviour.
Non-stimulant medications act differently. Atomoxetine selectively inhibits noradrenaline reuptake, helping improve attention and impulse control without producing the same rapid clinical effects as stimulants. Although the term stimulant may appear contradictory when treating hyperactivity, these medications can improve behavioural regulation rather than simply increasing activity. Patients may experience better concentration, reduced restlessness and greater control over their responses. The clinical effects depend on medication type, dose, individual metabolism and treatment response.
How Long Does ADHD Medication Take to Work?
The onset and duration of ADHD medication vary considerably between preparations. Some medicines become effective within the first hour, while others require several weeks of continuous treatment before their full clinical benefit can be evaluated.
ADHD Medication: Onset and Duration
Short-acting stimulants may require several daily doses, whereas extended-release preparations are designed to provide a longer period of symptom control with fewer administrations. The medication with the longest duration is not necessarily the most appropriate. Its effect should match the patient’s daily routine without causing unacceptable adverse effects, particularly insomnia or appetite suppression.
| Medication | Approximate onset | Typical duration |
|---|---|---|
| Ritalin immediate-release | 30–60 minutes | 3–4 hours |
| Concerta extended-release | 30–60 minutes | 10–12 hours |
| Vyvanse | 1–2 hours | 10–13 hours |
| Strattera | Gradual improvement over 2–6 weeks | Ongoing effect with daily use |
Methylphenidate for ADHD: Ritalin and Concerta
Methylphenidate is a well-established stimulant medication used in the treatment of ADHD. It primarily blocks the reuptake of dopamine and noradrenaline, increasing their availability in neuronal signalling pathways involved in attention and executive functioning. Methylphenidate is available in immediate-release and extended-release formulations. Although both contain the same active substance, their clinical effects differ because of the way the medication is released.
Ritalin: Immediate-Release Methylphenidate
Immediate-release methylphenidate typically begins working within 30–60 minutes and has a clinical duration of approximately three to four hours. Its shorter duration allows flexible dosing and can be useful when symptom control is required during particular periods of the day. However, some patients need more than one dose to maintain adequate coverage. The timing of administration requires careful planning to avoid fluctuations in symptom control or interference with sleep.
Concerta: Extended-Release Methylphenidate
Concerta® is an extended-release formulation designed to deliver methylphenidate in successive phases throughout the day. It combines an initial release with a controlled delivery system, providing an effect that typically lasts around 10–12 hours. The extended duration can be helpful for adults who require consistent symptom control during work, studies and daily responsibilities.
Compared with multiple immediate-release doses, once-daily treatment may simplify medication routines and improve adherence. The selection of immediate-release or extended-release methylphenidate depends on the required duration of symptom control, tolerability and individual response.
Lisdexamfetamine for ADHD: Vyvanse
Lisdexamfetamine (Vyvanse®) is a long-acting stimulant medication used to treat ADHD. It is a prodrug that is converted in the body, primarily in red blood cells, into dexamfetamine, its pharmacologically active component. Dexamfetamine increases dopamine and noradrenaline signalling, helping regulate attention, impulse control and behavioural activity.
Lisdexamfetamine generally begins to take effect within one to two hours after administration. Its clinical effect commonly lasts approximately 10–13 hours, although some patients experience a longer or shorter duration. Because it is taken once daily, lisdexamfetamine may be suitable for adults who need sustained symptom control throughout much of the day.
Its gradual conversion into the active substance contributes to its characteristic pharmacological profile. Nevertheless, lisdexamfetamine remains a controlled stimulant with potential for misuse and dependence, making appropriate prescribing and monitoring important. The decision to use lisdexamfetamine rather than methylphenidate depends on individual effectiveness, tolerability, previous treatment response and clinical circumstances.
Atomoxetine for ADHD: Strattera
Atomoxetine (Strattera®) is a non-stimulant ADHD medication that selectively inhibits the reuptake of noradrenaline. It influences neurotransmission in brain networks involved in attention, executive functioning and impulse control. Atomoxetine is particularly relevant when stimulant medication is not suitable, poorly tolerated or insufficiently effective.
Unlike methylphenidate and lisdexamfetamine, atomoxetine does not produce rapid symptom improvement after the first dose. Its therapeutic effects develop gradually, making consistent daily administration important. Some patients experience improvement during the first two to four weeks, but others need a longer trial before the effectiveness of treatment can be evaluated adequately.
Once an effective response is established, atomoxetine can provide more continuous symptom control without the pronounced daily peaks and declines associated with short-acting stimulants. Atomoxetine is not considered to have the same misuse potential as stimulant medications. However, it can still produce adverse effects, including nausea, reduced appetite, sleep disturbances, increased heart rate or blood pressure, and sexual side effects in some adults. Its advantages and limitations should therefore be considered in the context of the individual patient’s needs.
Other Medications Used for ADHD
Bupropion
Bupropion is an antidepressant that affects noradrenaline and dopamine signalling. It is sometimes prescribed off-label for adults with ADHD, particularly when there are coexisting depressive symptoms or when established ADHD medications are unsuitable. The evidence supporting bupropion in ADHD is less extensive than that for standard stimulant treatments. Its use should therefore be individually assessed, taking into account contraindications, possible adverse effects and other treatment options.
Guanfacine
Guanfacine is a selective alpha-2A adrenergic receptor agonist that influences noradrenergic signalling in the prefrontal cortex. It is used in ADHD treatment in certain patient groups and jurisdictions. However, its role in adult ADHD is more limited, and prescribing for adults may be off-label or require specialist advice depending on the applicable guidance. Its availability and regulatory status in Dubai should be confirmed before considering treatment.
Centanafadine (Simtriyo): A New ADHD Medication Approved in 2026
Centanafadine, marketed as Simtriyo, received US Food and Drug Administration approval in 2026 for ADHD treatment in eligible adults and paediatric patients. Centanafadine has a different pharmacological profile from established ADHD medicines. It inhibits the reuptake of noradrenaline, dopamine and serotonin, making it a triple reuptake inhibitor.
Clinical trials demonstrated improvement in ADHD symptoms compared with placebo. However, clinical experience with centanafadine remains more limited than with long-established medications such as methylphenidate and lisdexamfetamine. It is not yet possible to conclude that centanafadine is more effective or better tolerated than standard ADHD treatments without sufficient direct comparative evidence.
Unlike atomoxetine, centanafadine is classified as a central nervous system stimulant in its US prescribing information. Although it has a distinct pharmacological mechanism, it also requires appropriate assessment of cardiovascular and misuse-related risks.
Is Centanafadine Available in Dubai?
FDA approval in the United States does not automatically establish UAE approval or availability. Centanafadine can be prescribed in Dubai only if the applicable regulatory requirements and supply conditions are satisfied. Patients should not assume that Simtriyo is available through UAE pharmacies. Its local registration and availability should be verified before discussing it as a practical treatment option.
Which ADHD Medication Is Best for Adults?
There is no single ADHD medication that provides the best results for every adult. Although stimulants are generally recommended as first-line pharmacological treatments, individual responses differ considerably. Medication selection depends on symptom severity, treatment goals, daily routine, coexisting psychiatric or medical conditions, previous treatment experiences and the likelihood of adverse effects.
For example, a patient requiring symptom control throughout a long working day may benefit from an extended-release preparation. Another patient may respond better to a shorter-acting medication or a non-stimulant alternative. The most effective ADHD medication is the one that provides meaningful improvement in daily functioning with acceptable tolerability. Sometimes this can be achieved with the first prescribed medicine, while other patients require dose adjustments or a change of treatment.
The objective is not to prescribe the strongest medication, but to establish an effective, sustainable treatment regimen suited to the individual.
Possible Side Effects of ADHD Medication
Most ADHD medications are generally well tolerated when appropriately prescribed, although adverse effects can occur and vary between substances and individuals. Common side effects of stimulant medications include reduced appetite, difficulty sleeping, headache, gastrointestinal discomfort, dry mouth, restlessness and increases in heart rate or blood pressure. Some patients experience anxiety, irritability or mood changes, particularly when the dose is unsuitable.
Non-stimulant medications have different side-effect profiles. Atomoxetine may cause nausea, fatigue, dizziness, appetite reduction or sexual side effects, as well as changes in pulse or blood pressure. Less common but clinically important complications may involve cardiovascular symptoms or psychiatric deterioration, depending on the medication and the patient’s underlying vulnerabilities.
Adverse effects do not necessarily mean that ADHD medication must be discontinued. In many cases, adjusting the dose, timing or formulation can improve tolerability. More serious symptoms require prompt medical assessment. Patients should report persistent or troublesome side effects to their prescribing psychiatrist rather than independently changing the medication.
Starting ADHD Medication: Dose Adjustment and Monitoring
ADHD medication is usually introduced at a low dose and adjusted progressively according to clinical response and tolerability. This process, known as dose titration, helps establish an effective dose while limiting adverse effects. During titration, the psychiatrist evaluates changes in attention, impulsivity and daily functioning alongside sleep, appetite, mood and physical symptoms. Follow-up appointments are generally more frequent during this period.
Before treatment, assessment includes medical and psychiatric history, current medications, blood pressure, heart rate, weight and cardiovascular risk factors. Depending on the patient’s clinical circumstances, additional investigations may be indicated.
At CHMC Dubai, the pre-treatment assessment includes laboratory investigations and an ECG as part of the clinic’s evaluation protocol. However, international guidelines do not require routine ECGs or laboratory tests for every patient starting ADHD medication.
Once the medication and dose have been stabilised, follow-up focuses on maintaining effectiveness, identifying adverse effects and adapting treatment when necessary. Long-term monitoring remains important because the patient’s symptoms, medical condition, daily responsibilities and response to treatment may change over time.
ADHD Medication in Dubai: UAE Prescribing Regulations
ADHD medication in Dubai is subject to UAE pharmaceutical regulations. The prescribing requirements depend on the medication’s legal classification, with stimulant and certain non-stimulant preparations subject to additional controls.
Methylphenidate and lisdexamfetamine are regulated stimulant medications. Their prescription and dispensing require compliance with applicable UAE controlled-medication procedures.
Atomoxetine is a non-stimulant, but its regulatory status should not be confused with its pharmacological classification. Non-stimulant medicines may also be subject to specific prescription controls under UAE regulations.
Medication availability may change according to registration status, pharmacy supply and regulatory requirements. A medicine commonly prescribed in Europe or the United States is not necessarily available in Dubai.
ADHD Medication Prescriptions for UAE Residents
UAE residents should bring their valid physical Emirates ID when attending appointments involving regulated prescriptions. At CHMC Dubai, identity verification is required as part of the clinic’s electronic prescribing procedures.
Patients previously treated abroad should bring their psychiatric reports, medication history and current dosage information. These documents can help the psychiatrist evaluate previous treatment, although they do not replace an appropriate clinical assessment.
Can Visitors Receive ADHD Medication in Dubai?
Visitors may be eligible for ADHD prescriptions following psychiatric assessment, subject to the legal classification of the medication, identification requirements and current UAE prescribing rules. Patients visiting Dubai should bring their passports, previous prescriptions and relevant medical reports. They should not assume that a prescription issued in another country can automatically be dispensed by a UAE pharmacy.
Can ADHD Medication Be Stopped?
ADHD medication does not necessarily have to be continued indefinitely. The appropriate duration depends on symptom persistence, functional impairment, treatment benefits and the patient’s individual circumstances. Some adults benefit from ongoing pharmacological treatment, while others may wish to reassess their need for medication after a period of stability.
Any decision to reduce or discontinue ADHD medication should be discussed with the prescribing psychiatrist. Stopping treatment may result in the return of symptoms, and some medicines require gradual dose reduction to minimise discontinuation effects. Periodic review helps determine whether the medication remains beneficial, whether adjustments are necessary or whether a supervised discontinuation trial is appropriate.
Can ADHD Medication Be Combined with Psychotherapy?
Medication and psychotherapy address different aspects of ADHD management and can complement one another. Medication primarily targets core symptoms such as inattention, impulsivity and hyperactivity. Psychotherapy and behavioural interventions can help patients manage persistent difficulties with organisation, emotional regulation, procrastination and interpersonal functioning. Psychological treatment can be particularly valuable when symptoms continue to affect daily life despite an adequate medication response.
The broader therapeutic approach is described in our dedicated articles on ADHD treatment in Dubai and psychotherapy for ADHD.
Why Choose CHMC for ADHD Medication Management in Dubai?
At CHMC German Clinic for Psychiatry and Psychology in Dubai, Dr. Gregor Kowal, German Board-Certified Consultant Psychiatrist and Psychotherapist, provides specialist ADHD medication management based on more than 30 years of clinical experience in Germany and the UAE.
Treatment combines comprehensive psychiatric evaluation, medical safety assessment and individualised medication selection. Particular attention is given to coexisting psychiatric conditions, previous treatment experiences and the patient’s personal circumstances.
Medication is carefully introduced, adjusted and monitored, with regular follow-up appointments to assess its effectiveness, tolerability and long-term benefits. When clinically appropriate, pharmacotherapy can be combined with psychotherapy to address psychological and everyday difficulties associated with ADHD.
If ADHD symptoms are affecting your work, studies, relationships or daily functioning, contact CHMC Dubai to schedule a specialist consultation with Dr. Kowal and discuss whether ADHD medication is an appropriate treatment option.
FAQs About ADHD Medication in Dubai
Which ADHD medications are commonly prescribed in Dubai?
Established ADHD medications include methylphenidate (Ritalin®, Concerta®), lisdexamfetamine (Vyvanse®) and atomoxetine (Strattera®). The choice depends on clinical suitability, regulatory requirements and current local availability.
What is the first-line medication for adult ADHD?
Methylphenidate and lisdexamfetamine are generally recommended as first-line pharmacological treatments for adults with ADHD. Atomoxetine is an established alternative when stimulants are unsuitable, poorly tolerated or insufficiently effective.
How long does ADHD medication last?
Immediate-release methylphenidate typically works for approximately three to four hours, while extended-release methylphenidate and lisdexamfetamine can provide symptom control for much of the day. Atomoxetine develops its effects gradually and can provide continuous symptom management with regular daily dosing.
Can ADHD medication cause dependence?
Stimulant medications have misuse and dependence potential and are therefore regulated. Appropriate patient selection, individualised prescribing and regular monitoring can reduce these risks. Non-stimulants such as atomoxetine do not have the same misuse potential.
Is ADHD medication safe for long-term use?
ADHD medication can be used long term when clinical benefits outweigh potential risks. Regular follow-up is important to monitor effectiveness, cardiovascular parameters, weight, sleep, mental health and adverse effects.
Do I need an Emirates ID to receive ADHD medication in Dubai?
UAE residents generally need their valid Emirates ID for prescriptions issued through the regulated electronic prescribing system. At CHMC Dubai, patients should bring the physical card for identity verification.
Can I switch from one ADHD medication to another?
Yes. Changing medication may be appropriate when symptom improvement is insufficient, side effects are troublesome or the duration of action does not meet the patient’s needs. Switching should be planned and supervised by the prescribing psychiatrist.
Medically reviewed by
German Board-Certified Consultant Psychiatrist and Psychotherapist
Dr. Gregor Kowal is the Medical Director of CHMC German Clinic for Psychiatry and Psychology in Dubai. A graduate of the University of Heidelberg, he has more than 30 years of clinical experience in psychiatry and psychotherapy in Germany and the UAE. His clinical work combines psychiatric assessment, pharmacotherapy and psychotherapy.
